Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol
Files in This Item:
|Brayden_Researchgate_21052015.docx||534.74 kB||Microsoft Word||Download|
|Title:||Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol||Authors:||Brayden, David James
Walsh, Edwin G.
|Permanent link:||http://hdl.handle.net/10197/6622||Date:||Aug-2015||Online since:||2016-05-27T01:00:13Z||Abstract:||Epithelial damage caused by intestinal permeation enhancers is a source of debate over their safety. The medium chain fatty acid, sodium caprate (C10), causes reversible membrane perturbation at high dose levels required for efficacy in vivo, so the aim was to model it in vitro. Exposure of Caco-2 monolayers to 8.5mM C10 for 60min followed by incubation in fresh buffer led to (i) recovery in epithelial permeability (i.e. transepithelial electrical resistance (TEER) and apparent permeability coefficient (Papp) of [(14)C]-mannitol), (ii) recovery of cell viability parameters (monolayer morphology, plasma membrane potential, mitochondrial membrane potential, and intracellular calcium) and (iii) reduction in mRNA expression associated with inflammation (IL-8). Pre-incubation of monolayers with a mucosal prostaglandin cytoprotectant was attempted in order to further decipher the mechanism of C10. Misoprostol (100nM), inhibited C10-induced changes in monolayer parameters, an effect that was partially attenuated by the EP1 receptor antagonist, SC51322. In rat isolated intestinal tissue mucosae and in situ loop instillations, C10-induced respective increases in the [(14)C]-mannitol Papp and the AUC of FITC-dextran 4000 (FD-4) were similarly inhibited by misoprostol, with accompanying morphological damage spared. These data support a temporary membrane perturbation effect of C10, which is linked to its capacity to mainly increase paracellular flux, but which can be prevented by pre-exposure to misoprostol.||Funding Details:||Irish Research Council
Science Foundation Ireland
|Type of material:||Journal Article||Publisher:||Elsevier||Journal:||European Journal of Pharmaceutics and Biopharmaceutics||Volume:||94||Start page:||194||End page:||206||Copyright (published version):||2015 Elsevier||Keywords:||Oral peptide delivery; Medium chain fatty acids; Sodium caprate; Caco-2 monolayers; Intestinal permeation enhancers; Cytotoxicity assays||DOI:||10.1016/j.ejpb.2015.05.013||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Irish Drug Delivery Network Research Collection|
Veterinary Medicine Research Collection
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.